These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12648055)

  • 1. Cystoid macular oedema associated with brimonidine therapy.
    Kim P; Lertsumikul S
    Clin Exp Ophthalmol; 2003 Apr; 31(2):165-6. PubMed ID: 12648055
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystoid macular edema associated with latanoprost use in a pseudophakic eye with a history of surgical complications.
    Watanabe K; Hayasaka S; Hayasaka Y; Nagaki Y; Watanabe K
    Jpn J Ophthalmol; 2003; 47(1):110-2. PubMed ID: 12586189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brimonidine/Timolol: a viewpoint by Robert M. Feldman.
    Feldman RM
    Drugs Aging; 2006; 23(9):762-3. PubMed ID: 17020401
    [No Abstract]   [Full Text] [Related]  

  • 4. Update in glaucoma: the new pharmacotherapies. Brimonidine versus apraclonidine.
    Crichton AC
    Can J Ophthalmol; 1998 Aug; 33(5):254-5; discussion 257-8. PubMed ID: 9740952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Increased myopia and metaporphosia in a 59-year old patient. Serous retinal detachment of the posterior pol after latanoprost administration].
    Sauer S; Coracas A; Eckhardt C
    Ophthalmologe; 2003 Jan; 100(1):62-3. PubMed ID: 12608405
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel therapy in paclitaxel-related cystoid macular edema: Brimonidine.
    Güven YZ; Akbalık T
    J Fr Ophtalmol; 2023 May; 46(5):e154-e156. PubMed ID: 36828725
    [No Abstract]   [Full Text] [Related]  

  • 7. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost.
    Lima MC; Paranhos A; Salim S; Honkanen R; Devgan L; Wand M; Gaudio AR; Shields MB
    J Glaucoma; 2000 Aug; 9(4):317-21. PubMed ID: 10958605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brimonidine/Timolol: a viewpoint by Richard Fiscella.
    Fiscella R
    Drugs Aging; 2006; 23(9):762-3. PubMed ID: 17020400
    [No Abstract]   [Full Text] [Related]  

  • 9. Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.
    Artunay O; Yuzbasioglu E; Unal M; Rasier R; Sengul A; Bahcecioglu H
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):513-7. PubMed ID: 20874499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral and simultaneous cystoid macular edema associated with latanoprost use: report of two cases.
    Brasil OF; Brasil MV; Ventura MP; Maia HS
    Arq Bras Oftalmol; 2010; 73(2):186-8. PubMed ID: 20549052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brimonidine/Timolol: a viewpoint by Francisco J. Goñi.
    Goñi FJ
    Drugs Aging; 2006; 23(9):762-3. PubMed ID: 17020402
    [No Abstract]   [Full Text] [Related]  

  • 12. Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery.
    Altintaş O; Yüksel N; Karabaş VL; Demirci G
    Eur J Ophthalmol; 2005; 15(1):158-61. PubMed ID: 15751259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic reactions to brimonidine in patients treated for glaucoma.
    Blondeau P; Rousseau JA
    Can J Ophthalmol; 2002 Feb; 37(1):21-6. PubMed ID: 11865954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystoid macular edema associated with ocular hypotensive lipids.
    Wand M; Gaudio AR
    Am J Ophthalmol; 2002 Mar; 133(3):403-5. PubMed ID: 11860980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins and cystoid macular edema.
    Miyake K; Ibaraki N
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S203-18. PubMed ID: 12204717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.
    Goñi FJ;
    Eur J Ophthalmol; 2005; 15(5):581-90. PubMed ID: 16167288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serous detachment of macula in cystoid macular edema associated with latanoprost.
    Ozdemir H; Karacorlu M; Karacorlu SA
    Eur J Ophthalmol; 2008; 18(6):1014-6. PubMed ID: 18988179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
    Nguyen QH; Earl M
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost.
    Carrillo MM; Nicolela MT
    Am J Ophthalmol; 2004 May; 137(5):966-8. PubMed ID: 15126179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial.
    Cantor LB; Safyan E; Liu CC; Batoosingh AL
    Curr Med Res Opin; 2008 Jul; 24(7):2035-43. PubMed ID: 18534052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.